SRSF1-DLAT axis drives mitochondrial fusion to confer therapy resistance in diabetes-associated pancreatic ductal adenocarcinoma

Zuwei Wang, Yiting Chen, Jinpeng Lu, Haoxiang Zhang, Yu Pan, Shuncang Zhu, Hongyi Lin, Ge Li, Yinhao Chen, Chengyu Liao, Long Huang, Yifeng Tian, Shi Chen

Open source

DOI
10.1016/j.drup.2026.101489
Published
2027-01
Container
Drug Resistance Updates
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.drup.2026.101489,
  title = {SRSF1-DLAT axis drives mitochondrial fusion to confer therapy resistance in diabetes-associated pancreatic ductal adenocarcinoma},
  author = {Zuwei Wang and Yiting Chen and Jinpeng Lu and Haoxiang Zhang and Yu Pan and Shuncang Zhu and Hongyi Lin and Ge Li and Yinhao Chen and Chengyu Liao and Long Huang and Yifeng Tian and Shi Chen},
  year = {2027},
  journal = {Drug Resistance Updates},
  doi = {10.1016/j.drup.2026.101489},
  url = {https://doi.org/10.1016/j.drup.2026.101489}
}

RIS

TY  - JOUR
TI  - SRSF1-DLAT axis drives mitochondrial fusion to confer therapy resistance in diabetes-associated pancreatic ductal adenocarcinoma
AU  - Zuwei Wang
AU  - Yiting Chen
AU  - Jinpeng Lu
AU  - Haoxiang Zhang
AU  - Yu Pan
AU  - Shuncang Zhu
AU  - Hongyi Lin
AU  - Ge Li
AU  - Yinhao Chen
AU  - Chengyu Liao
AU  - Long Huang
AU  - Yifeng Tian
AU  - Shi Chen
PY  - 2027
JO  - Drug Resistance Updates
DO  - 10.1016/j.drup.2026.101489
UR  - https://doi.org/10.1016/j.drup.2026.101489
ER  - 

APA

Wang, Z., Chen, Y., Lu, J., Zhang, H., Pan, Y., Zhu, S., Lin, H., Li, G., Chen, Y., Liao, C., Huang, L., Tian, Y., & Chen, S. (2027). SRSF1-DLAT axis drives mitochondrial fusion to confer therapy resistance in diabetes-associated pancreatic ductal adenocarcinoma. Drug Resistance Updates. https://doi.org/10.1016/j.drup.2026.101489

Source records